Copyright
©The Author(s) 2019.
World J Biol Chem. Nov 21, 2019; 10(3): 44-64
Published online Nov 21, 2019. doi: 10.4331/wjbc.v10.i3.44
Published online Nov 21, 2019. doi: 10.4331/wjbc.v10.i3.44
Protein | Expression/overexpression | Cancer types | Ref. |
HABP4 | Expression | Hodgkin’s lymphoma | Kobarg et al[112] |
HABP4 | Expression | B-cell lymphatic leukemia | Kobarg et al[112] |
HABP4 | Expression | non-Hodgkin-T-cell lymphoma | Kobarg et al[112] |
HABP4 | Expression | Bladder | Kobarg et al[112] |
SERBP1 | Overexpression | Ovarian | Koensgen et al[51] |
SERBP1 | Overexpression | Breast | Serce et al[144] |
SERBP1 | Overexpression | Colon | Wang et al[81] |
SERBP1 | Overexpression | Prostate | Guo et al[145] |
SERBP1 | Overexpression | Lung | Sun et al[147] |
SERBP1 | Overexpression | Glioblastoma | Hlavaty et al[146] |
- Citation: Colleti C, Melo-Hanchuk TD, da Silva FRM, Saito Â, Kobarg J. Complex interactomes and post-translational modifications of the regulatory proteins HABP4 and SERBP1 suggest pleiotropic cellular functions. World J Biol Chem 2019; 10(3): 44-64
- URL: https://www.wjgnet.com/1949-8454/full/v10/i3/44.htm
- DOI: https://dx.doi.org/10.4331/wjbc.v10.i3.44